218 studies found for:    "Diabetic Nephropathies"
Show Display Options
Rank Status Study
21 Completed Effect of Pyridorin in Patients With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: Pyridorin (pyridoxamine dihydrochloride)
22 Recruiting Safety, Tolerability and Pharmacokinetic Study of MT-3995 at a Low Dose in Subjects With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: MT-3995;   Drug: Placebo
23 Completed Effect of Pyridorin in Patients With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: Pyridorin (pyridoxamine dihydrochloride)
24 Completed Study of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic Nephropathy
Conditions: Chronic Glomerulonephritis;   Diabetic Nephropathy
Intervention: Drug: olmesartan medoxomil
25 Unknown  Association Between Rosiglitazone Use and Clinical Course of Diabetic Nephropathy: Population-Based Study
Conditions: Diabetes;   Diabetic Nephropathy;   Renal Protection
Intervention: Drug: Rosiglitasone (retrospective observation)
26 Completed Evaluation Study for the Programme DiaNe for People With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Behavioral: DiaNe consultation and support program
27 Active, not recruiting Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Type 2 Diabetes
Intervention: Biological: Mesenchymal Precursor Cells (MPCs)
28 Completed Evaluating the Renoprotective Effect of Milk Thistle Extract on Patients With Type II Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: placebo;   Drug: Milk Thistle extract
29 Recruiting Pyridorin in Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Diabetic Kidney Disease
Interventions: Drug: Pyridorin;   Drug: Placebo
30 Recruiting Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria
Conditions: Diabetic Nephropathy;   Diabetic Retinopathy
Interventions: Drug: Spironolactone;   Drug: Placebo;   Drug: Standard care
31 Completed
Has Results
ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial
Conditions: Diabetic Nephropathy;   Type 2 Diabetes Mellitus;   Proteinuria
Interventions: Drug: olmesartan medoxomil;   Drug: Placebo Tablets
32 Recruiting Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy
Conditions: Diabetes Mellitus, Type 2;   Diabetic Nephropathies
Interventions: Drug: Canagliflozin;   Drug: Placebo
33 Recruiting Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy
Conditions: Diabetes Type 2;   Diabetic Nephropathy;   Vascular Disease
Interventions: Drug: Ramipril;   Drug: Clopidogrel
34 Recruiting A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria
Condition: Diabetic Nephropathy
Interventions: Drug: MT-3995 Low;   Drug: MT-3995 High;   Drug: Placebo
35 Active, not recruiting Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan)
Condition: Diabetic Nephropathies
Interventions: Drug: BAY94-8862;   Drug: Placebo;   Drug: BAY 94-8862
36 Recruiting A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFR
Condition: Diabetic Nephropathy
Interventions: Drug: MT-3995 Low;   Drug: MT-3995 High;   Drug: Placebo
37 Enrolling by invitation Increased Activity of a Renal Salt Transporter (ENaC) in Diabetic Kidney Disease
Conditions: Diabetic Nephropathies;   Hypertension
Interventions: Dietary Supplement: Standardized salt diet;   Drug: Amiloride
38 Completed
Has Results
The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System Inhibitors
Conditions: Diabetic Nephropathy;   Chronic Kidney Disease
Interventions: Drug: Zemplar (paricalcitol ) capsules;   Drug: Zemplar (paricalcitol) capsules;   Drug: Placebo
39 Completed
Has Results
Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy
Conditions: Type 2 Diabetes;   Overt Diabetic Nephropathy
Interventions: Drug: Rosiglitazone;   Drug: Placebo
40 Completed Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease
Conditions: Diabetes Mellitus, Type I;   Diabetic Nephropathy
Intervention: Drug: Lisinopril

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years